Correvio Pharma Corp. Deferred Tax Assets, Net of Valuation Allowance
Correvio Pharma Corp. had Deferred Tax Assets, Net of Valuation Allowance of $300.00 thousand as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2020-04-30
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $300.00K.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $383.00K.
- 2017-12-31: Deferred Tax Assets, Net of Valuation Allowance $320.00K.
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance $460.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2019-12-31 | $300.00K 20-F · filed 2020-04-30 |
| 2018-12-31 | $383.00K 20-F · filed 2020-04-30 |
| 2017-12-31 | $320.00K 40-F · filed 2019-03-13 |
| 2016-12-31 | $460.00K 20-F · filed 2018-04-30 |
| 2015-12-31 | $469.00K 40-F · filed 2017-03-29 |
| 2014-12-31 | $439.00K 40-F · filed 2016-03-29 |
| 2013-12-31 | $0.00 40-F · filed 2015-03-27 |
| 2012-12-31 | $0.00 40-F/A · filed 2014-04-30 |
| 2011-12-31 | $0.00 20-F/A · filed 2013-04-18 |